Jiangsu NHWA Pharmaceutical
VC Fund
Xuzhou, China
Jiangsu NHWA Pharmaceutical is a VC fund in Xuzhou focused on Medical and Therapeutics. Jiangsu Enhua Pharmaceutical Co., Ltd. is strategically positioned in the central nervous drug market, mainly engaged in the development, production and sales of central nervous system drugs. It is a company specializing in the market segment of central nervous drugs. The main categories include anesthesia and spirit. Class and Neurology, throughyears of unremitting efforts in product development, production and service, the company has established a complete series of central nervous system drug products and marketing network, and strive to build an important domestic producer and sales of central nervous system drugs. Business.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Jiangsu NHWA Pharmaceutical invests in
Stages Jiangsu NHWA Pharmaceutical invests in
Countries Jiangsu NHWA Pharmaceutical invests in
Investment Focus
Industry
- Medical 1 (100%)
- Therapeutics 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Neuro3 Therapeutics
|
Neuro3 Therapeutics is a Hong Kong based company that advances medicines for CNS diseases. | $3.5M / Seed / Mar 06, 2025 |
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Jiangsu NHWA Pharmaceutical invest in?
Jiangsu NHWA Pharmaceutical invests primarily in Medical and Therapeutics startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Hong Kong. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Jiangsu NHWA Pharmaceutical last invest?
The most recent investment recorded for Jiangsu NHWA Pharmaceutical closed in Mar 2025. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
